- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 25.34M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 24.27M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 20.32M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.14M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $11.81M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.98M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $48.36M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $32.86M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $35.78M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $37.49M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.81M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.9M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.38M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $18.62M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $33.19M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $25.06M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $59.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $51.48M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $42.06M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.68M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.34M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $503.05K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $739.67K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.52M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.84M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.62M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.89M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.57M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.19M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.78M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.41M |
| Revenue | Q1 2026 · Mar 31, 2026 | $5.35M |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.6M |
| Capex | Q1 2026 · Mar 31, 2025 | $361.05K |